Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/twist-bioscience-corp">Twist Bioscience </a>is a market leader in the synthetic biology space, leveraging a proprietary silicon-based DNA synthesis platform that provides a significant cost and throughput advantage over traditional methods.</li>
  <li>The company is demonstrating a strong growth trajectory with rapidly increasing revenues and improving gross margins, driven by expanding its core synthetic DNA business and growing its presence in Next-Generation Sequencing (NGS) tools and Biopharma services.</li>
  <li>Despite its technological leadership and revenue growth, the company has a history of significant net losses and negative cash flow. The path to sustained profitability remains a key focus, with the company guiding towards achieving adjusted EBITDA breakeven.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Twist Bioscience is a market leader in the synthetic biology space, leveraging a proprietary silicon-based DNA synthesis platform that provides a significant cost and throughput advantage over traditional methods.
  The company is demonstrating a strong growth trajectory with rapidly increasing revenues and improving gross margins, driven by expanding its core synthetic DNA business and growing its presence in Next-Generation Sequencing (NGS) tools and Biopharma services.
  Despite its technological leadership and revenue growth, the company has a history of significant net losses and negative cash flow. The path to sustained profitability remains a key focus, with the company guiding towards achieving adjusted EBITDA breakeven.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Twist Bioscience  (TWST US) - Aug 2026

United States

Twist Bioscience Corporation operates as a biotechnology company. The Company specializes in synthetic DNA such as biodetection, functional genomics, genome engineering, drugs and biodefense, and data storage. Twist Bioscience serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Twist Bioscience (TWST US) - Aug 2026

Twist Bioscience is a market leader in the synthetic biology space, leveraging a proprietary silicon-based DNA synthesis platform that provides...

αSK Primers